サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ヘルニアメッシュデバイスの世界市場-2023年～2030年
市場調査レポート
商品コード
1372609

ヘルニアメッシュデバイスの世界市場-2023年～2030年

Global Hernia Mesh Devices Market - 2023-2030

出版日
ページ情報
英文 190 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
ヘルニアメッシュデバイスの世界市場-2023年～2030年
出版日: 2023年10月18日
発行: DataM Intelligence
ページ情報: 英文 190 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

ヘルニアメッシュは、弱った筋肉とヘルニアを修復するために、しこりの近くに外科的に設置されます。これは、生物学的、合成材料からなる薄くて多孔性の織物状の材料で、外科手術の際に損傷した組織に強度と構造を提供します。

鼠径ヘルニアは鼠径部に発生する最も一般的なタイプのヘルニアで、医療専門家がメッシュを装着して修復します。鼠径ヘルニアは、一生の間に男性の10～15%、女性の2%に発生します。

市場促進要因：市場抑制要因

ヘルニア修復手術の増加

ヘルニアは、腹部の筋肉壁の弱い部分から内臓が突出することで発生します。これにより、胃の皮膚の下、通常は皮膚の近くに異常な膨らみが生じる。ヘルニアメッシュデバイスは鼠径部や臍部に装着され、内臓のしこりや筋肉への負担を修復します。ヘルニアとヘルニア修復手術の有病率は世界的に増加しています。

例えば、米国食品医薬品局（FDA）によると、2023年、米国では年間推定100万件の鼠径ヘルニア修復手術が行われています。これらの手術は年間約2,000万件と推定され、ヘルニア修復手術は世界中で最も一般的に行われている一般外科手術の一つとなっています。

米国小児科学会（American Academy of Pediatrics）によると、2023年、鼠径ヘルニアの発生率は出生1,000人あたり8～50人近くであり、低体重児では約20％に増加します。

さらに、International Journal of Medical Sciences, 2023によると、有病率は南北アメリカで4.36％、欧州で4.06％、東南アジアで4.88％です。鼠径ヘルニアの生涯有病率は女性（3～6％）より男性の方がはるかに高い（20～27％）。

メッシュを用いた手術によるヘルニアの再発

鼠径ヘルニアの再発は、ヘルニアを修復した後に多くの患者で観察されます。最良の手術手技と対策を行っても、不適切なメッシュの設置、メッシュの吸収など多くの理由により、メッシュを設置した後にヘルニアの再発がみられます。縫合修復後の再発率は8.2％、メッシュ修復後の再発率は2.7％でした。再発率は使用するメッシュの素材によっても異なります。Baylor College of Medicine, 2023によると、ヘルニア修復の最大30％が再発する可能性があることが研究で示されています。

このレポートの詳細について- サンプル請求

目次

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • ヘルニア修復手術の増加
      • YY
    • 抑制要因
      • メッシュを使用した手術によるヘルニアの再発
      • YY
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • ヘルニア疾患統計
  • 規制分析
  • DMI見解

第6章 COVID-19分析

第7章 ヘルニアタイプ別

  • 鼠径ヘルニア
  • 切開ヘルニア
  • 臍ヘルニア
  • 大腿ヘルニア
  • 裂孔ヘルニア
  • その他

第8章 製品タイプ別

  • 合成メッシュ
    • 吸収性
    • 非吸収性
    • ハイブリッド
  • 動物由来メッシュ
  • その他

第9章 メッシュサイズ別

  • 15cm x 9cm
  • 15センチ×10センチ

第10章 エンドユーザー別

  • 病院およびクリニック
  • 専門センター
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他のアジア太平洋
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第13章 企業プロファイル

  • Medtronic plc
  • C. R. Bard Inc
  • Ethicon Inc
  • Atrium Medical Technologies
  • W. L. Gore & Associates, Inc
  • B. Braun Melsungen AG
  • LifeCell Corporation
  • Baxter International, Inc
  • Cook Medical Incorporated
  • Herniamesh S.r.l

第14章 付録

目次
Product Code: MD1610

Overview

Hernia mesh is placed surgically near the lumpy area to repair the weakened muscle and the hernia. It is a thin, porous, woven material made up of biological, synthetic materials that provide strength and structure to damaged tissue during surgical procedures.

Inguinal hernias are the most common type of hernia in the groin area, where healthcare professionals place and repair the mesh. Inguinal hernias occur between 10 and 15 percent of males and 2 percent of women during their lifetimes.

Market Dynamics: Drivers & Restraints

Increasing incidence of hernia repair surgeries

Hernia occurs when the internal organs protrude through a weak area in the muscular wall of the abdomen. This gives rise to an abnormal bulge under the stomach's skin, usually near the skin. Hernia mesh devices are placed at the groin or naval area so that the organs' lumps and stress on the muscle are repaired. The prevalence of hernia and hernia repair surgeries is increasing worldwide.

For instance, according to the Us Food and Drug Administration, 2023, an estimated 1 million inguinal hernia repairs are performed yearly in the US. These surgeries are estimated at nearly 20 million a year, making hernia repair surgeries one of the most commonly performed general surgery procedures worldwide.

According to the American Academy of Pediatrics, 2023, the incidence of inguinal hernias is nearly 8 to 50 per 1000 live births, increasing to approximately 20% in deficient birth weight infants.

Furthermore, according to the International Journal of Medical Sciences, 2023, the prevalence is 4.36% in the Americas, 4.06% in Europe, and 4.88% in Southeast Asia. Men reported a much higher lifetime prevalence of inguinal hernias (20-27%) than women (3-6%).

Hernia recurrences with surgeries using mesh

Recurrent inguinal hernia is observed in many patients after the hernia is repaired. Even after the best surgical technique and measures, hernia recurrence is seen after placing a mesh due to many reasons like improper mesh placement, mesh absorption, etc. The recurrence rates were 8.2 percent after suture repair and 2.7 percent after mesh repair. The recurrence also depends upon the mesh material used. According to Baylor College of Medicine, 2023, studies have shown that up to 30% of hernia repairs can result in a recurrence.

For more details on this report - Request for Sample

Segment Analysis

The global hernia mesh devices are segmented based on hernia type, product type, mesh size, end user and region.

The Synthetic mesh segment accounted for approximately 43.3% of the market share

The synthetic mesh is expected to hold the largest segment due to its wide application in hernia repair surgeries. Synthetic meshes are either permanent, as in the case of nonabsorbable, or temporary, as absorbable. It is made up of materials like polyester, polypropylene, etc.

These are the most common types of materials used in hernia surgeries. Product launch with advancements brings more efficacy to the procedure performed on the patient suffering from a hernia.

For instance, in April 2022, Ariste Medical, LLC, a pre-commercial drug & device company, received FDA approval for its drug-embedded, synthetic hernia mesh in the United States to reduce microbial infections during surgical implantation.

In February 2022, Futura Surgicare Pvt. Ltd., an Indian-based medical device manufacturer, has recently introduced a range of surgical meshes under its brand Dolphin Mesh. These tension-free dual surgical meshes can be used for laparoscopic tension-free hernia repairs.

Geographical Analysis

North America accounted for approximately 40.2% of the market share in 2022

North America is expected to hold the largest market share due to the rising prevalence of hernia cases and surgeries among the U.S. population. For instance, according to the Cleveland Clinic Organisation, hiatal hernias affect around 20% of people in the U.S. and 50% over 50.

For instance, according to Springer Nature Journal, in the United States alone, 500,000 and 750,000 patients are operated on for inguinal hernias annually.

Additionally, around 90% of hernia surgeries annually in the U.S. use hernia mesh. Usually, there are no causes or symptoms of hernia. A lump can be seen protruding from the stomach area, abdomen area, and groin area.

COVID-19 Impact Analysis:

COVID-19 impacted the hernia mesh devices market due to the worldwide disruption in the supply chain. There is a shift in the focus of the research and development towards COVID-19 vaccines and drugs. As lockdowns were implemented worldwide, the diagnostic procedures were postponed to later stages; hence, the surgeries were halted during COVID-19 unless they were essential. This has impacted the hernia meshes as the devices are not used for treatment. The number of hospital visits has drastically decreased during the period, and hence, most of the diagnostic centers did not prioritize hernia repairs.

Competitive Landscape

The major global players in the hernia mesh devices market include: Medtronic plc, C. R. Bard Inc., Ethicon Inc., Atrium Medical Technologies, W. L. Gore & Associates, Inc., B. Braun Melsungen AG, LifeCell Corporation, Baxter International, Inc, Cook Medical Incorporated, Herniamesh S.r.l among others.

Key Developments

  • In June 2023, Advanced Medical Solutions Group plc received US Food and Drug Administration approval for the use of LiquiBandFix8 to to fix mesh to tissue inside the body during inguinal hernia surgery. It has also been approved for closing the peritoneum, a membrane that surrounds the abdominal cavity.
  • In May 2023, Tissium, a tissue reconstruction company, secured $53.8m to launch its tissue repair platform and to commercialize other products that are in the pipeline, nerve repair, hernia repair, and cardiovascular sealants.

Why Purchase the Report?

  • To visualize the global hernia mesh devices market segmentation based on hernia type, product type, mesh size, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of hernia mesh devices market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global hernia mesh devices market report would provide approximately 69 tables, 68 figures, and 190 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Hernia Type
  • 3.2. Snippet by Product Type
  • 3.3. Snippet by Mesh Size
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Driver
      • 4.1.1.1. Increasing incidence of hernia repair surgeries
      • 4.1.1.2.
    • 4.1.2. Restraints
      • 4.1.2.1. Hernia recurrences with surgeries using mesh
      • 4.1.2.2.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Hernia Disease Statistics
  • 5.5. Regulatory Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Hernia Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hernia Type
    • 7.1.2. Market Attractiveness Index, By Hernia Type
  • 7.2. Inguinal Hernia*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Incisional Hernia
  • 7.4. Umbilical Hernia
  • 7.5. Femoral Hernia
  • 7.6. Hiatal Hernia
  • 7.7. Others

8. By Product Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.1.2. Market Attractiveness Index, By Product Type
  • 8.2. Synthetic Mesh*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
      • 8.2.2.1. Absorbable
      • 8.2.2.2. Non-absorbable
      • 8.2.2.3. Hybrid
  • 8.3. Animal-derived Mesh
  • 8.4. Others

9. By Mesh Size

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mesh Size
    • 9.1.2. Market Attractiveness Index, By Mesh Size
  • 9.2. 15 cm x 9 cm*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. 15 cm x 10 cm

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals and Clinics*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Specialty Centers
  • 10.4. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hernia Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mesh Size
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hernia Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mesh Size
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hernia Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mesh Size
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hernia Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mesh Size
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hernia Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Mesh Size
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Medtronic plc
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. C. R. Bard Inc
  • 13.3. Ethicon Inc
  • 13.4. Atrium Medical Technologies
  • 13.5. W. L. Gore & Associates, Inc
  • 13.6. B. Braun Melsungen AG
  • 13.7. LifeCell Corporation
  • 13.8. Baxter International, Inc
  • 13.9. Cook Medical Incorporated
  • 13.10. Herniamesh S.r.l

LIST NOT EXHAUSTIVE.

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us